tiprankstipranks
Advertisement
Advertisement

OCS Stock Latest News

Oculis price target lowered to $23 from $42 at JPMorgan
The FlyOculis price target lowered to $23 from $42 at JPMorgan
20m ago
OCS
Oculis price target lowered to $38 from $49 at Baird
PremiumThe Fly
Oculis price target lowered to $38 from $49 at Baird
1d ago
OCS
Oculis price target lowered to $38 from $49 at Baird
PremiumThe Fly
Oculis price target lowered to $38 from $49 at Baird
2d ago
OCS
Video: Nvidia rallies after taking wraps off new PC processor
PremiumThe Fly
Video: Nvidia rallies after taking wraps off new PC processor
2d ago
AMD
OCS
Oculis price target lowered to $35 from $44 at BofA
PremiumThe Fly
Oculis price target lowered to $35 from $44 at BofA
2d ago
OCS
Oculis price target lowered to $38 from $46 at Needham
PremiumThe FlyOculis price target lowered to $38 from $46 at Needham
2d ago
OCS
Oculis price target lowered to $45 from $75 at Guggenheim
Premium
The Fly
Oculis price target lowered to $45 from $75 at Guggenheim
2d ago
OCS
Oculis price target lowered to $26 from $47 at H.C. Wainwright
Premium
The Fly
Oculis price target lowered to $26 from $47 at H.C. Wainwright
2d ago
OCS
Oculis price target lowered to $40 from $50 at Stifel
PremiumThe Fly
Oculis price target lowered to $40 from $50 at Stifel
2d ago
OCS
Oculis Maintained at Buy as Analyst Lowers Price Target to $45, Refocuses on Optic Neuritis Opportunity
PremiumRatings
Oculis Maintained at Buy as Analyst Lowers Price Target to $45, Refocuses on Optic Neuritis Opportunity
2d ago
OCS
Analyst Maintains Buy on Oculis, Sees Upside Driven by Optic Neuropathy and Dry Eye Pipelines Despite OCS-01 Phase 3 Setback
PremiumRatings
Analyst Maintains Buy on Oculis, Sees Upside Driven by Optic Neuropathy and Dry Eye Pipelines Despite OCS-01 Phase 3 Setback
3d ago
OCS
Oculis Holding AG trading resumes
PremiumThe Fly
Oculis Holding AG trading resumes
5d ago
OCS
Oculis reports primary endpoint of DIAMOND Phase 3 trials was not met
PremiumThe FlyOculis reports primary endpoint of DIAMOND Phase 3 trials was not met
5d ago
OCS
Oculis Holding AG trading halted, news pending
Premium
The Fly
Oculis Holding AG trading halted, news pending
5d ago
OCS
Oculis quickly falls 26% to $22 per share
Premium
The Fly
Oculis quickly falls 26% to $22 per share
5d ago
OCS
Etsy upgraded, ZoomInfo downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Etsy upgraded, ZoomInfo downgraded: Wall Street’s top analyst calls
13d ago
KD
RM
Oculis initiated with a Buy at Guggenheim
PremiumThe Fly
Oculis initiated with a Buy at Guggenheim
14d ago
OCS
Oculis price target raised to $42 from $38 at JPMorgan
PremiumThe Fly
Oculis price target raised to $42 from $38 at JPMorgan
16d ago
OCS
Oculis AGM Backs All Proposals, Adds Veteran Biotech CFO to Board and Expands Capital Flexibility
PremiumCompany Announcements
Oculis AGM Backs All Proposals, Adds Veteran Biotech CFO to Board and Expands Capital Flexibility
20d ago
6K
OCS
Oculis price target raised to $47 from $44 at H.C. Wainwright
PremiumThe FlyOculis price target raised to $47 from $44 at H.C. Wainwright
22d ago
OCS
Oculis price target raised to $44 from $43 at BofA
Premium
The Fly
Oculis price target raised to $44 from $43 at BofA
22d ago
OCS
Oculis reports Q1 EPS (49c), consensus (41c)
Premium
The Fly
Oculis reports Q1 EPS (49c), consensus (41c)
23d ago
OCS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >